Caron Jacobson, MD, MMSc

Dana-Farber Cancer Institute

Disclosure(s): Abintus Bio: Advisor/Consultant; Bluebird Bio: Advisor/Consultant; BMS/Celgene: Advisor/Consultant; Daiichi-Sankyo: Advisor/Consultant; Epizyme: Advisor/Consultant; ImmPACT Bio: Advisor/Consultant; Instill Bio: Advisor/Consultant; Ipsen: Advisor/Consultant; Kite/Gilead: Advisor/Consultant, Grant/Research Support; Lonza: Advisor/Consultant; Novartis: Advisor/Consultant; Pfizer: Grant/Research Support

Poster(s):

• 1939 - COVID-19 vaccine immunogenicity among CD19 receptor T-cell (CAR-T) therapy
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 2097 - Bacterial Infections in the Setting of Late Neutropenia Following CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Non-Hodgkin Lymphoma (NHL)
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET